Related keylists
View moreBoston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.
Headquarters
United States of America
Address
300 Boston Scientific Way, Marlborough, Massachusetts, 01752-1291
Telephone
1 508 6834000
No of Employees
45,000
Industry
Medical Equipment
Ticker Symbol & Exchange
BSX (NYSE)
Revenue (2022)
$12.7B
6.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-32.9%
(2022 vs 2021)
Market Cap*
$78.1B
Net Profit Margin (2022)
XYZ
-37.1%
(2022 vs 2021)
* As of and is in US$
Boston Scientific Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Gynecology Products | Endotak Reliance |
| Pulmonology Products | Contak Renewal |
| Electrophysiology Products | Confient |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In September, the company entered into an agreement to acquire Relievant Medsystems, Inc., a medical technology company. |
| 2023 | Regulatory Approval | In September, the company secured an approval from the U.S. Food and Drug Administration for WATCHMAN FLX Pro Left Atrial Appendage Closure (LAAC) device. |
| 2023 | Regulatory Approval | In August, the company secured an approval from the U.S. Food and Drug Administration for the POLARx Cryoablation System. |
Competitor Comparison
| Key Parameters | Boston Scientific Corp | Johnson & Johnson | Abbott Laboratories | Medtronic Plc | Nevro Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Ireland | United States of America |
| City | Marlborough | New Brunswick | Abbott Park | Dublin | Redwood City |
| State/Province | Massachusetts | New Jersey | Illinois | - | California |
| No. of Employees | 45,000 | 152,700 | 115,000 | 95,000 | 1,087 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Michael F. Mahoney | Chairman; President; Chief Executive Officer | Executive Board | 2016 | 58 |
| Daniel J. Brennan | Executive Vice President; Chief Financial Officer | Senior Management | 2014 | 57 |
| Mary Beth Moynihan | Chief Marketing Officer; Senior Vice President - Market Access | Senior Management | 2021 | - |
| Ian T. Meredith | Chief Medical Officer; Executive Vice President | Senior Management | 2017 | 66 |
| Kenneth Stein | Senior Vice President; Chief Medical Officer - Global | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward